WebFeb 28, 2024 · As of December 31, 2024, Novavax had $1.5 billion in cash, cash equivalents, marketable securities and restricted cash, compared to $0.8 billion as of December 31, 2024. Financial Guidance... WebApr 4, 2024 · NOVAVAX, INC. ... NVAX The Nasdaq Global Select Market share Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230. ...
NVAX Stock Price Novavax Inc. Stock Quote (U.S.: Nasdaq)
WebNov 30, 2024 · Novavax began the day with a market cap of around $8.0 billion with approximately 63.66 million shares outstanding and a short interest of about 14%. NVAX shares opened 5% lower today at $119.26 (-$6.43, … WebMar 1, 2024 · Novavax reported a net loss of $177.6 million, or $2.70 per share, for the fourth quarter of 2024, compared to a net loss of $31.8 million, or $1.13 per share, for the … incontinence in early pregnancy
NVAX Novavax Inc. Stock Overview (U.S.: Nasdaq) Barron
WebSep 23, 2013 · 4,153,950 Over-Allotment Shares . Novavax, Inc. UNDERWRITING AGREEMENT . September 23, 2013 . LAZARD CAPITAL MARKETS LLC. As Representative of the several ... (other than a change in the number of outstanding shares of Common Stock due to the issuance of shares upon the exercise of outstanding options or warrants), or … WebApr 6, 2024 · "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted … WebAug 5, 2024 · Financial Results for the Three Months Ended June 30, 2024. Novavax reported a net loss of $352 million, or $4.75 per share, for the second quarter of 2024, compared to a net loss of $18 million ... incontinence hypnosis